TFF Pharmaceuticals, Inc.
USD0.07
-0.10 (-60.05%)
CEO
Harlan F. Weisman
IPO Date
2019-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.09
Prev. Close
$0.16
Day Low
$0.06
Day High
$0.09
52W Low
$0.06
52W High
$11.00
Market Cap
$0.00B
Volume
11.02M
| -1.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -80.0% | -76.1% | 0.00 | 19.81 | -7.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -49.4% | -47.7% | 0.00 | 28.41 | -15.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -42.5% | -40.3% | 0.00 | 71.08 | -3.1 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -41.6% | -36.9% | 0.00 | 8.88 | -24.3 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 9743.9% | 0.0% | 0.00 | 0.00 | -12650.1 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 0.00 | -252.6 |
| -0.4 |
| 31 Mar 2024 | Q1 | 31.0% | -2821.4% | -108.1% | -62.4% | 0.02 | 1.26 | -0.7 |
| 31 Dec 2023 | Q4 | 82.2% | -648.9% | -49.8% | -39.6% | 0.01 | 3.13 | -0.9 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -32.2% | -29.6% | 0.01 | 9.54 | -0.9 |
| 30 Jun 2023 | Q2 | 62.9% | -1506.0% | -40.9% | -37.0% | 0.01 | 7.75 | -0.8 |
| 31 Mar 2023 | Q1 | -139.5% | -13403.2% | -41.7% | -37.8% | 0.01 | 8.85 | -0.9 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -32.3% | -30.6% | 0.01 | 16.83 | -1.3 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -40.3% | -35.9% | 0.01 | 8.18 | -88.9 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -36.5% | -31.3% | 0.01 | 6.58 | -102.4 |